Fast atom bombardment mass spectrometry and gas chromatography-mass spectrometry were used to analyze bile acids in the body fluids of an infant (L.C.) whose liver contained no immunoreactive peroxisomal 3-oxoacyl-CoA thiolase. The profiles were compared with those of six patients with undetectable peroxisomes (Zellweger syndrome) and two siblings (N.B. and I.B.) whose defect of peroxisomal fl-oxidation could not be localized by morphological studies of peroxisomes or by immunoblotting of peroxisomal fl-oxidation proteins.
Introduction
Chenodeoxycholic acid and cholic acid are synthesized from cholesterol by a series of reactions involving modifications to the steroid nucleus and oxidation of the side chain (1) . The major pathway for cholic acid synthesis proceeds via the 27-carbon bile acid-3a,7a, 1 2a-trihydroxy-5,B-cholestan-26-oic acid (trihydroxycoprostanic acid, THCA).' Oxidation of 1. Abbreviations used in this paper: CRM, cross-reacting material; FAB-MS, fast atom bombardment mass spectrometry, GC(-MS) gasliquid chromatography (-mass spectrometry); VLCFA, very long chain THCA to cholic acid occurs in the hepatic peroxisomes (2) and is thought to proceed via a series of reactions similar to the peroxisomal (3-oxidation of fatty acids (Fig. 1) . The first enzyme in the peroxisomal fl-oxidation sequence is an acyl-CoA oxidase that introduces the C2-C3 double bond. The second and third steps of peroxisomal A-oxidation are both catalyzed by a "bifunctional protein," which has enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase activity. Finally a peroxisomal 3-oxoacyl-CoA thiolase splits off acetyl-CoA (3, 4) .
The oxidation of THCA to cholic acid in the peroxisomes is thought to occur in an analogous fashion to the fl-oxidation of fatty acids (as shown in Fig. 1 ) via the coenzyme A esters of 3a,7a, 1 2a-trihydroxy-5,B-cholest-24-en-26-oic acid (A24-THCA), 3a,7a, 1 2a,24-tetrahydroxy-5f-cholestan-26-oic acid (24-hydroxy-THCA or varanic acid) and 3a,7a, 12a-trihydroxy-24-oxo-5fl-cholestan-26-oic acid (24-oxo-THCA). Similar intermediates are considered to participate in the peroxisomal pathway for conversion of 3a,7a-dihydroxy-5fl-cholestanoic acid (dihydroxycoprostanic acid, DHCA) to chenodeoxycholic acid (1) . It should be emphasized, however, that there is only limited evidence for these pathways in man. Swell et al. showed that varanic acid could be converted to cholic acid in man but it was a poorer precursor of cholic acid than THCA (5) .
The study of patients with peroxisomal defects has contributed considerably to our understanding of peroxisomal biochemistry. Patients with Zellweger syndrome lack normal peroxisomes; as a result they cannot oxidize very long chain fatty acids (VLCFA) and show impaired conversion of THCA to cholic acid (6, 7) . In 1986, Goldfischer et al. described a patient with clinical, biochemical, and pathological features similar to those seen in Zellweger syndrome. Peroxisomes were present in the patient's liver but nonetheless there was an abnormal accumulation of VLCFA and THCA (8) . Subsequently, Schram et al. showed that peroxisomal fl-oxidation was impaired due to CRM -ve peroxisomal thiolase deficiency; an antibody to the thiolase detected no immunoreactive protein (cross-reacting material, CRM) in the liver (9) . Schram et al. fatty acids (> C22). Bile acids, alcohols, and sterols: THCA (trihydroxycoprostanic acid), 3a,7a, 12a-trihydroxy-5fl-cholestan-26-oic acid; A\23-THCA and A24-THCA indicate 3a,7a,12a-trihydroxy-5fl-cholest-23-en-26-oic and -24-en-26-oic acids respectively; varanic acid or 24-hydroxy-THCA, 3a,7a, 1 2a,24-tetrahydroxy-5fl-cholestan-26-oic acid; 1I#-hydroxy-, 6a-hydroxy-, and 25-hydroxy-THCA indicate Il,3a,7a, 12a-tetrahydroxy-, 3a,6a,7a, I 2a-tetrahydroxy-, and 3a, 7a, 12a,25-tetrahydroxy-5fl-cholestan-26-oic acids respectively; 26-hydroxy-THCA, 3a,7a, 12a,26-tetrahydroxy-5i3-cholestan-27-oic acid; 24-oxo-THCA, 3a,7a, 12a-trihydroxy-24-oxo-5,B-cholestan-26-oic acid; DHCA (dihydroxycoprostanic acid), 3a,7a-dihydroxy-5,B-cholestan-26-oic acid; A24-DHCA, 3a,7a-dihydroxy-5fl-cholest-24-en-26-oic; 24-hydroxy-DHCA, 3a,7a,24-trihydroxy-5,B-cholestan- 26 -oic acid; C29-dicarboxylic acid, 3a,7a, 122a-trihydroxy-5jB-27a, 27b-dihomo-5fB-cholestan-26,27b-dioic acid; 5fl-ranol, 27-nor-5fl- pointed out that the accumulation of THCA in the patient's duodenal juice indicated that peroxisomal 3-oxoacyl-CoA thiolase participates in the oxidative cleavage of the THCA side chain. Since the thiolase catalyzes the last step in the reaction sequence proposed in Fig. 1 , it would be reasonable to expect accumulation of the other intermediates in the pathway, A24-THCA, varanic acid, and 24-oxo-THCA. The present study was undertaken firstly to test whether such intermediates could be detected, thereby providing further evidence for the occurrence of the proposed pathway in man, and secondly to provide reference bile acid profiles for comparison with profiles from patients suspected of having thiolase deficiency. A recent report documented three siblings with "pseudo-Zellweger" syndrome whose bile contained more varanic acid than THCA. Immunoreactive peroxisomal thiolase and bifunctional protein were present in the liver. Six patients with Zellweger syndrome were compared with L.C., N.B., and I.B. They were aged between 7 d and 11 mo when studied. All were shown to have undetectable peroxisomes in their liver biopsy, reduced activity of dihydroxyacetone phosphate acyl transferase in skin fibroblasts and elevated plasma VLCFA and C27 bile acid concentrations (1 1, 12) .
Procedures. Bile acids were extracted from urine by passing it through a cartridge of octadecylsilane bonded silica (1 1). Duodenal juice was diluted with 5 vol of water and subjected to the same extraction procedure. The plasma was diluted with 4 vol of 0.1 M sodium hydroxide before passage through the cartridge (13) . After washing with water and hexane, the bile acids from all three samples were eluted from their respective cartridges with 10 ml ofmethanol. A small aliquot of the urine and bile extracts was analyzed by fast atom bombardment mass spectrometry [FAB-MS], recording negative ions between m/z 200 and 1,000 (1 1). All three extracts (bile, plasma, and urine) were analyzed by gas chromatography-mass spectrometry (GC-MS) and two different methods were used for the hydrolysis ofglycineand taurine-conjugated bile acids. For enzyme hydrolysis the extract was dissolved in 5 ml of 0.15 M sodium acetate buffer, pH 5.6, and incubated with 90 U ofcholylglycine hydrolase for 3 h at 370C (12, 14, 15) . For alkaline hydrolysis the extract was dissolved in 15 ml of4.5 M sodium hydroxide and heated to 130'C for 24 h in a Teflon®-lined stainless steel digestion vessel (1 1, 16 ). In the case ofthe plasma extract, the free bile acids were extracted on XAD-2 resin (12, 14, 15) ; in the case of the bile and urine extracts, the bile acids were extracted on a Lipidex 1000 column after adjusting the pH to 3-4 (11, 16, 17) . Methylation with diazomethane, purification of methyl esters on a small column of neutral alumina and silylation (TriSil", 65°C, 1 h) were performed as described previously (11, 12, 14, 15) . However, the bile acid methyl ester trimethylsilyl ethers were then injected into the gas chromatograph in TriSil6 without further purification on Lipidex 5000. In addition to the GC and GC-MS conditions described previously (1 1, 12), samples were analyzed on a Pye 4550 gas chromatograph fitted with a 25-m, 0.25 mm i.d., fused silica capillary column coated with a chemically bonded BPA1 (OVl equivalent) stationary phase (0.25 gm film thickness) from Philips Scientific Co., Cambridge, UK. The bile acid derivatives were transferred to the column using an all-glass falling needle solid injection device with the injection point and initial column temperature at 200°C. The carrier gas was helium (2 ml/min) and chromatograms were recorded from a flame ionization detector. Some of the GC-MS data was obtained using a Hewlett Packard 5970 mass selective detector (Hewlett Packard Co., Palo Alto, CA) and ChemStation data system. GC conditions were as described previously (12); the ion source temperature was 1 70°C and the ionization energy 70 eV. Spectra were compared with reference compounds (see below). For quantitation the chromatograms obtained with the flame ionization detector were used and the calculations were based on peak heights. For bile and urine a percent composition was determined assuming identical response factors for all bile acids. For plasma, concentrations in micromoles per liter were calculated by relating peak heights to that of the internal standard (14) .
Reference compounds. Bile acids in the patients' samples were identified by comparing retention times and electron impact mass spectra with those of reference compounds. A number of useful reference compounds were obtained from the bile of Varanus salvator. The bile acids released by alkaline hydrolysis were methylated and the methyl esters separated by chromatography on a 2-g column of neutral alumina as described previously (15, 18) . Fig. 2 . The major bile acids were chenodeoxycholic acid (peak 1) and 24-hydroxy-THCA-I (peak 11). Next in order of magnitude were 24-hydroxy-THCA-2 (peak 12), THCA (peak 6), and cholic acid (peak 2). Among the smaller peaks a series of unsaturated analogues of THCA were identified. Peak The spectrum was very similar to that quoted by Noma et al. for 3a,7a, 1 2a-trihydroxy-27-nor-5/3-cholestan-24-one (24) .
The retention time was also in agreement: when the derivatized sample from L.C. was analyzed on a packed OV I column peak 4 had a relative retention time of 1.21 using as a reference peak the methyl ester TMS ether of cholic acid; the figure § Relative retention time on OV 17 packed column. 1 vealed that these patients secreted bile with a much lower percentage of varanic acid (Table II) . The percentage of the C24-hydroxylated derivatives of THCA was similar to the percentages of C25-and C26-hydroxylated derivatives of THCA in the bile of these patients. By contrast, enzyme hydrolysis of bile from I.B. and N.B., the two siblings with suspected thiolase or 3-hydroxyacyl-CoA dehydrogenase deficiency (10) yielded a similar mixture of bile acids to that found in the bile from L.C. (TableII). In particular, varanic acid was the major C27 bile acid and both A24-THCA [the (24E)-and (24Z)-isomers] and A23-THCA (two isomers) were detected. There were, however, some differences: Firstly, the varanic acid in the duodenal juice from I.B. and N.B. was almost exclusively the 24-hydroxy-THCA-1. Secondly, a small peak of retention index 3593 was present in enzyme-hydrolyzed bile from both N.B. and I.B. but not L.C. This peak produced a spectrum containing ions m/z 604,514 and 424 and we previously suggested that it may be 24-oxo-THCA (10). However, an alternative explanation for these ions would be the presence of a tetrahydroxycholestenoic acid with one hydroxyl group not derivatised. Similar tetrahydroxycholestenoic acids were found in the urine of N.B. (see below). The bile alcohol detected in bile from L.C. (3a,7a,12a-trihydroxy-27-nor-5,3-cholestan-24-one) was also found in the bile from N.B. and I.B.
Substantial amounts of C27 bile acids were detected when the bile samples were analyzed following enzyme hydrolysis of conjugates. However, the FAB-MS analysis indicated that these were probably actually present largely in unconjugated form. The negative ion FAB mass spectrum obtained from the duodenal bile of L.C. is shown in Fig. 3 . The major ions are listed in Table III alongside the major ions in the FAB mass spectra from the bile of I.B. and N.B. and the proposed identitie. of the ions. All three FAB mass spectra showed a major peak (m/z 465) attributable to unconjugated varanic acid. Only in the bile from I.B. was a peak attributable to tauro-varanic acid (m/z 572) detected. By contrast, all three analyses revealed that C24 bile acids were present as the glycine and When GC-MS analyses of bile were performed after alkaline hydrolysis, the results suggested that artefacts were produced using this method. For example enzyme-hydrolyzed bile from I.B. showed a large peak attributable to (24R,25S)-varanic acid. On the chromatogram obtained following alkaline hydrolysis this peak was absent and a large peak due to (24Z)-A24-THCA was present instead. This indicated that alkali-induced dehydration of 24-hydroxy-THCA-1 to (24Z)-A24-THCA can occur. Alkali-hydrolyzed bile from L.C. also contained a higher percentage of (24Z)-A24-THCA than the enzyme-hydrolyzed samples (Table II) . Enzyme-hydrolyzed bile from L.C. contained mostly the 24-hydroxy-THCA-I but the alkali-hydrolyzed sample contained an equal amount of the 24-hydroxy-THCA-2 indicating that alkaline hydrolysis had converted some of the 24-hydroxy-THCA-1 to 24-hydroxy-THCA-2.
Plasma. C27 bile acids were detected on GC-MS analysis of the plasma ofpatient L.C. with CRM -ve thiolase deficiency (enzyme hydrolyzed sample). The concentrations were considerably lower than the concentrations of chenodeoxycholic and cholic acids (Table IV) . The concentrations of THCA and varanic acid were approximately equal and no C29-dicarboxylic acid (3a,7a, 1 2a-trihydroxy-27a,27b-dihomo-5B-cholestan-26,27b-dioic acid) was detected. This plasma bile acid pattern was also observed in the two siblings with the unknown defect ofperoxisomal f-oxidation except that in these cases the concentrations of THCA and of 24-hydroxy-THCA-1 were greater, similar to those of chenodeoxycholic and cholic acid. By contrast, in the plasma of six infants with undetectable peroxisomes, the concentration of THCA was always greater than that of varanic acid and the C-29 dicarboxylic acid was always readily detectable.
Urine. After alkaline hydrolysis, GC-MS analysis of urine from L.C. showed that all bile acids were present at low concentration (as in the plasma). THCA, A24-THCA, and varanic acid were all present but again, the concentrations were less than that of cholic acid. The major components in the mixture of C24 and C27 bile acids in the urine were as follows: cholic acid, 38%; THCA' 8.2%; 24-hydroxy-THCA-1, 6.6%; 3/3,7a, 1 2a-trihydroxy-5/3-cholanic acid, 6.6%; 24-hydroxy-THCA-2, 4.1%; (24E)-A24-THCA, 3.9%; (24Z)-A24-THCA, 3.8%; chenodeoxycholic acid, 3 .1%. The results of GC-MS analyses of urine from our patients with undetectable peroxisomes have been described previously (11) . Tetrahydroxycholestanoic acids predominated but among these varanic acid was a minor component; the major tetrahydroxycholestanoic acids were nuclear-hydroxylated derivatives of THCA, e.g., l3-hydroxy-THCA, 6a-hydroxy-THCA. Urine from N.B., when analyzed by GC-MS after alkaline hydrolysis contained the following major components: 1I3,3a,7a, 12a-tetrahydroxy5f-cholanic acid, 16%; 1 f3,3a,7a, 12a-tetrahydroxy-53-cholestanoic acid plus 3a,6a,7a, 12a-tetrahydroxy-5f-cholestanoic acid, 12%; (?3,4,7,12-)tetrahydroxycholestenoic acid (RI = 3669), 12%; cholic acid, 10%; THCA, 8%; tetrahydroxycholestenoic acid (RI = 3632), 8%. The tentatively identified tetrahydroxycholestenoic with a retention index of 3669 pro- sis. This, together with an ion at m/z 572 from the taurineconjugated tetrahydroxycholestanoic acids, were the dominant bile acid ions in the urine spectrum. FAB-MS analysis of urine from L.C. (CRM -ve peroxisomal thiolase deficiency) did not show an ion at m/z 572 or an ion at m/z 570. A small ion of m/z 556 just above background was tentatively attributed to the presence of taurine-conjugated THCA. When the results of the GC-MS analysis were available (see above) it became clear that the low intensity of ions attributable to C27 bile acids in the FAB mass spectrum from the urine ofL.C. was attributable to the small amounts of C27 bile acids present.
Discussion
The results reported above have important implications with regard to proposed pathways for bile acid and alcohol synthesis in man, the nature of the enzyme defect in N.B. and I.B. and the use of bile, plasma, and urine analyses to detect patients with peroxisomal thiolase deficiency.
Pathways ofbile acid and bile alcohol synthesis. The accumulation of large amounts of varanic acid in bile in peroxisomal thiolase deficiency provides strong evidence for the pathway in Fig. 1 A23-THCA is not on the pathway shown in Fig. 1 and so its presence in the bile of L.C. also requires explanation. Again the answer may lie in the operation of a peroxisomal isomerase, this time the A3-,trans-A2-enoyl-CoA isomerase (27) . This enzyme, if active on (24E)-A24-THCA would lead to the formation of A23-THCA.
The detection of 3a,7a, 1 2a-trihydroxy-27-nor-5/3-cholestan-24-one in the bile of L.C. is of interest with regard to the postulated mechanism for synthesis of C26 bile alcohols in man. When Noma et al. found this oxo bile alcohol in the bile of Rana catesbeiana, it led them to postulate a pathway involving decarboxylation of 24-oxo-THCA as the mechanism by which 5f,-ranol (27-nor-5j3-cholestan-3a,7a, 12a,24,26-pentol) is synthesized from cholesterol, 5f3-cholestan3a,7a, 12a-triol, and varanic acid in this amphibian (24) . Karlaganis et al. postulated that the same decarboxylation reaction in man could lead to the synthesis of C26 bile alcohols, e.g., 27- nor-5fl-cholestan-3a,7a, 1 2a,24,25-pentol (28) . The fact that 3a,7a, 1 2a-trihydroxy-5,B-cholestan-24-one accumulates when metabolism of 24-oxo-THCA is blocked by peroxisomal thiolase deficiency suggests that this pathway may indeed occur in man.
The remaining compounds identified in this study can be accounted for on the basis of microsomal hydroxylation reactions. Microsomal hydroxylation of THCA in patients with Zellweger syndrome leads to the production of 1,B-and 6a-hydroxy derivatives (11) . It probably accounts for the small amounts of varanic acid in their bile and for the presence of 25-hydroxy-and 26-hydroxy-THCA in the bile of L.C. and the Zellweger patients.
Chenodeoxycholic acid was present at high concentration in bile from L.C., whereas intermediates in the (3-oxidation of DHCA were not detected. This suggests that peroxisomal (-oxidation ofDHCA may not be the only pathway for chenodeoxycholic acid synthesis. Alternatively, the absence of DHCA, A24-DHCA, and 24-hydroxy-DHCA may be explained by the fact that DHCA can undergo 12a-hydroxylation to produce THCA.
The synthesis of unconjugated varanic acid instead of conjugates of cholic acid does not appear to be associated with significant hepatic dysfunction. Standard liver function tests and the total bile acid concentration in the blood were normal in L.C. The concentration of unconjugated varanic acid in the plasma was lower than the concentrations of chenodeoxycholic and cholic acids, suggesting efficient clearance of varanic acid by the liver. The liver was histologically normal except for a mild degree of stellate portal fibrosis (8) . Patients (-oxidation is suspected in an infant. Simple noninvasive methods exist for obtaining the small amount of bile required to determine the bile acid profile and, using FAB-MS analysis, an answer can be obtained quickly.
It should be stressed that caution is necessary when interpreting FAB mass spectra. It is particularly difficult to be certain from FAB-MS alone that an unsaturated bile acid is present if the saturated analogue is also present in the sample. This is because for all bile acids a significant [M-H-2]-ion accompanies the [M-H]-ion and depending upon the ionization conditions this [M-H-21-ion may be 20-40% of the intensity ofthe parent ion. Also it is important to remember which body fluid is being studied. For example an ion of m/z 465 in urine is more likely to represent androsterone or etiocholanolone glucuronide than unconjugated varanic acid.
